Brief: Valeo Pharma Has Submitted A New Drug Submission With Health Canada Seeking Marketing Approval Of Redesca
17/03/2020 11:11
March 17 (Reuters) - Valeo Pharma Inc VPH.CD :
* VALEO PHARMA INC - HAS SUBMITTED A NEW DRUG SUBMISSION
WITH
HEALTH CANADA SEEKING MARKETING APPROVAL OF REDESCA
* VALEO PHARMA INC - EXPECTS APPROVAL FOR RESESCA FROM
HEALTH
CANADA IN FALL 2020 WITH COMMERCIAL AVAILABILITY SHORTLY
THEREAFTER
Source text for Eikon: ID:nCNWsF6yPa
Further company coverage: VPH.CD
(Reuters.Briefs@thomsonreuters.com)
Recent news on Valeo Pharma
See all newsBrief: Valeo Pharma Says Co Initiates Restructuring Proceedings
Brief: Valeo Pharma Amends Credit Facility With Sagard Healthcare Royalty Partners
Brief: Valeo Pharma Announces Restructuring Of Commercial Field Operations To Support Path To Profitability
Brief: Valeo Pharma Announces Appointment Of Mr. Al Moghaddam To Board Of Directors
Brief: Valeo Pharma Amends Agreement With Novartis Pharmaceuticals Canada